These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12999813)

  • 1. Antagonists of nucleic acid derivatives. VII. 2, 4-Diaminopyrimidines.
    HITCHINGS GH; FALCO EA; VANDERWERFF H; RUSSELL PB; ELION GB
    J Biol Chem; 1952 Nov; 199(1):43-56. PubMed ID: 12999813
    [No Abstract]   [Full Text] [Related]  

  • 2. 2, 4-Diaminopyrimidines as antagonists of folic acid and folinic acid.
    HITCHINGS GH; FALCO EA; ELION GB; SINGER S; WARING GB; HUTCHISON DJ; BURCHENAL JH
    Arch Biochem Biophys; 1952 Oct; 40(2):479-81. PubMed ID: 12997239
    [No Abstract]   [Full Text] [Related]  

  • 3. Hematological effects of certain 2,4-diaminopyrimidines, antagonists of folic acid metabolism.
    HAMILTON L; PHILIPS FS; STERNBERG SS; CLARKE DA; HITCHINGS GH
    Blood; 1954 Nov; 9(11):1062-81. PubMed ID: 13208758
    [No Abstract]   [Full Text] [Related]  

  • 4. 2,4-diaminopyrimidines. The cyclization of 6-phenacylthio and related derivatives to thieno[2,3-d]pyrimidines and thiazolo[3,2-c]pyrimidines.
    Roth B
    J Med Chem; 1969 Mar; 12(2):227-32. PubMed ID: 4306482
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis of some bis(2,4-diaminopyrimidines) and bis(2,4-diaminoquinazolines) as potential antimalarial agents.
    Hynes JB; Gratz RF; Ashton WT
    J Med Chem; 1972 Dec; 15(12):1332-3. PubMed ID: 4629015
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiopulmonary effects of antimalarial drugs. 3. Diaminopyrimidines: trimethoprim (WR 5949) and 5-piperonyl-2,4-diaminopyrimidine (WR 40,070).
    Matsuo S; Ruiz R; Smith J; Aviado DM
    Toxicol Appl Pharmacol; 1970 Jul; 17(1):130-50. PubMed ID: 5456632
    [No Abstract]   [Full Text] [Related]  

  • 7. Selective inhibition of Leishmania dihydrofolate reductase and Leishmania growth by 5-benzyl-2,4-diaminopyrimidines.
    Sirawaraporn W; Sertsrivanich R; Booth RG; Hansch C; Neal RA; Santi DV
    Mol Biochem Parasitol; 1988 Oct; 31(1):79-85. PubMed ID: 3185614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2,4-Diaminothieno(2,3-d)pyrimidines as antifolates and antimalarials. 3. Synthesis of 5,6-disubstituted derivatives and related tetracyclic analogs.
    Rosowsky A; Chen KK; Lin M
    J Med Chem; 1973 Mar; 16(3):191-4. PubMed ID: 4632695
    [No Abstract]   [Full Text] [Related]  

  • 9. PREPARATION AND GROWTH-INHIBITORY PROPERTIES OF NEW POLYCYCLIC 2,4-DIAMINOPYRIMIDINES.
    MODEST EJ; CHATTERJEE S; FOLEY GE; FARBER S
    Acta Unio Int Contra Cancrum; 1964; 20():112-4. PubMed ID: 14151862
    [No Abstract]   [Full Text] [Related]  

  • 10. 2,4-Diaminothieno(2,3-d)pyrimidines as antifolates and antimalarials. 2. Synthesis of 2,4-diaminopyrido(4',3':4,5)thieno(2,3-d)pyrimidines and 2,4-diamino-8H-thiopyrano(4',3':4,5)thieno(2,3-d)pyrimidines.
    Chaykovsky M; Lin M; Rosowsky A; Modest EJ
    J Med Chem; 1973 Mar; 16(3):188-91. PubMed ID: 4632694
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative structure-activity relationships of antimalarial and dihydrofolate reductase inhibition by quinazolines and 5-substituted benzyl-2,4-diaminopyrimidines.
    Hansch C; Fukunaga JY; Jow PY
    J Med Chem; 1977 Jan; 20(1):96-102. PubMed ID: 319234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2,4-Diaminothieno(2,3-d)pyrimidines as antifolates and antimalarials. 1. Synthesis of 2,4-diamino-5,6,7,8-tetrahydrothianaphthena(2,3-d)pyrimidines and related compounds.
    Rosowsky A; Chaykovsky M; Chen KK; Lin M; Modest EJ
    J Med Chem; 1973 Mar; 16(3):185-8. PubMed ID: 4632693
    [No Abstract]   [Full Text] [Related]  

  • 13. The development of the diaminopyrimidines.
    Burchall JJ
    J Antimicrob Chemother; 1979 Nov; 5(B):3-14. PubMed ID: 395152
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of nucleic acid synthesis by folic acid antagonists.
    SKIPPER HE; MITCHELL JH; BENNETT LL
    Cancer Res; 1950 Aug; 10(8):510-2. PubMed ID: 15434808
    [No Abstract]   [Full Text] [Related]  

  • 15. Partial reversal of the antileukemic action of folic acid antagonists by nucleic acids.
    SKIPPER HE; BELL M; CHAPMAN JB
    Cancer; 1951 Mar; 4(2):357-9. PubMed ID: 14821931
    [No Abstract]   [Full Text] [Related]  

  • 16. Application of neural networks: quantitative structure-activity relationships of the derivatives of 2,4-diamino-5-(substituted-benzyl)pyrimidines as DHFR inhibitors.
    So SS; Richards WG
    J Med Chem; 1992 Aug; 35(17):3201-7. PubMed ID: 1507206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STUDIES ON NUCLEIC ACID ANTAGONISTS. VII. SYNTHESIS AND CHARACTERIZATION OF 1,4,6-TRIAZAINDENES(5H-PYRROLO(3,2-D)PYRIMIDINES).
    IMAI K
    Chem Pharm Bull (Tokyo); 1964 Sep; 12():1030-42. PubMed ID: 14245264
    [No Abstract]   [Full Text] [Related]  

  • 18. Triazines and related products. Part XV. 2,4-Diaminopyrimidines and 2-aminopyrimidin-4(3H)-ones bearing 1,2,3-benzotriazinyl groups as potential dihydrofolic reductase inhibitors.
    Brown TB; Stevens MF
    J Chem Soc Perkin 1; 1975; (11):1023-8. PubMed ID: 1170192
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of a folic acid antagonist on nucleic acid metabolism.
    GOLDTHWAIT DA; BENDICH A
    J Biol Chem; 1952 May; 196(2):841-52. PubMed ID: 12981023
    [No Abstract]   [Full Text] [Related]  

  • 20. Antagonists of nucleic acid derivatives. VIII. Synergism in combinations of biochemically related antimetabolites.
    ELION GB; SINGER S; HITCHINGS GH
    J Biol Chem; 1954 Jun; 208(2):477-88. PubMed ID: 13174557
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.